BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 20148354)

  • 1. Suppression of the androgen receptor function by quercetin through protein-protein interactions of Sp1, c-Jun, and the androgen receptor in human prostate cancer cells.
    Yuan H; Young CY; Tian Y; Liu Z; Zhang M; Lou H
    Mol Cell Biochem; 2010 Jun; 339(1-2):253-62. PubMed ID: 20148354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of transcription factor Sp1 in quercetin-mediated inhibitory effect on the androgen receptor in human prostate cancer cells.
    Yuan H; Gong A; Young CY
    Carcinogenesis; 2005 Apr; 26(4):793-801. PubMed ID: 15661808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgenic induction of prostate-specific antigen gene is repressed by protein-protein interaction between the androgen receptor and AP-1/c-Jun in the human prostate cancer cell line LNCaP.
    Sato N; Sadar MD; Bruchovsky N; Saatcioglu F; Rennie PS; Sato S; Lange PH; Gleave ME
    J Biol Chem; 1997 Jul; 272(28):17485-94. PubMed ID: 9211894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The roles of c-Jun and CBP in the inhibitory effect of quercetin on prostate cancer cells].
    Yuan HQ; Guo HF; He ML; Kong F; Hu XY; Jiang AL; Xu X; Zhang JY; Charles YF
    Yao Xue Xue Bao; 2006 Sep; 41(9):819-24. PubMed ID: 17111826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-Jun has multiple enhancing activities in the novel cross talk between the androgen receptor and Ets variant gene 1 in prostate cancer.
    Cai C; Hsieh CL; Shemshedini L
    Mol Cancer Res; 2007 Jul; 5(7):725-35. PubMed ID: 17634427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear receptor interaction protein, a coactivator of androgen receptors (AR), is regulated by AR and Sp1 to feed forward and activate its own gene expression through AR protein stability.
    Chen PH; Tsao YP; Wang CC; Chen SL
    Nucleic Acids Res; 2008 Jan; 36(1):51-66. PubMed ID: 17984071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perillyl alcohol inhibits the expression and function of the androgen receptor in human prostate cancer cells.
    Chung BH; Lee HY; Lee JS; Young CY
    Cancer Lett; 2006 May; 236(2):222-8. PubMed ID: 16029925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen up-regulates vascular endothelial growth factor expression in prostate cancer cells via an Sp1 binding site.
    Eisermann K; Broderick CJ; Bazarov A; Moazam MM; Fraizer GC
    Mol Cancer; 2013 Feb; 12():7. PubMed ID: 23369005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitization of androgen refractory prostate cancer cells to anti-androgens through re-expression of epigenetically repressed androgen receptor - Synergistic action of quercetin and curcumin.
    Sharma V; Kumar L; Mohanty SK; Maikhuri JP; Rajender S; Gupta G
    Mol Cell Endocrinol; 2016 Aug; 431():12-23. PubMed ID: 27132804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium selenite inhibits interleukin-6-mediated androgen receptor activation in prostate cancer cells via upregulation of c-Jun.
    Gazi MH; Gong A; Donkena KV; Young CY
    Clin Chim Acta; 2007 May; 380(1-2):145-50. PubMed ID: 17346688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-Jun enhancement of androgen receptor transactivation is associated with prostate cancer cell proliferation.
    Chen SY; Cai C; Fisher CJ; Zheng Z; Omwancha J; Hsieh CL; Shemshedini L
    Oncogene; 2006 Nov; 25(54):7212-23. PubMed ID: 16732317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repression of androgen receptor in prostate cancer cells by phenethyl isothiocyanate.
    Wang LG; Liu XM; Chiao JW
    Carcinogenesis; 2006 Oct; 27(10):2124-32. PubMed ID: 16704988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen receptor induces EPHA3 expression by interacting with transcription factor SP1.
    Diao X; Chen X; Pi Y; Zhang Y; Wang F; Liu P; Gao Y; Wang X; Yang S; Lu S
    Oncol Rep; 2018 Aug; 40(2):1174-1184. PubMed ID: 29917167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The androgen receptor negatively regulates the expression of c-Met: implications for a novel mechanism of prostate cancer progression.
    Verras M; Lee J; Xue H; Li TH; Wang Y; Sun Z
    Cancer Res; 2007 Feb; 67(3):967-75. PubMed ID: 17283128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of androgen receptor signaling by selenite and methylseleninic acid in prostate cancer cells: two distinct mechanisms of action.
    Husbeck B; Bhattacharyya RS; Feldman D; Knox SJ
    Mol Cancer Ther; 2006 Aug; 5(8):2078-85. PubMed ID: 16928829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of c-Jun induced by quercetin and resverol inhibits the expression and function of the androgen receptor in human prostate cancer cells.
    Yuan H; Pan Y; Young CY
    Cancer Lett; 2004 Sep; 213(2):155-63. PubMed ID: 15327830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein arginine methyltransferase 5 functions as an epigenetic activator of the androgen receptor to promote prostate cancer cell growth.
    Deng X; Shao G; Zhang HT; Li C; Zhang D; Cheng L; Elzey BD; Pili R; Ratliff TL; Huang J; Hu CD
    Oncogene; 2017 Mar; 36(9):1223-1231. PubMed ID: 27546619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. alpha-Tocopheryl succinate and derivatives mediate the transcriptional repression of androgen receptor in prostate cancer cells by targeting the PP2A-JNK-Sp1-signaling axis.
    Huang PH; Wang D; Chuang HC; Wei S; Kulp SK; Chen CS
    Carcinogenesis; 2009 Jul; 30(7):1125-31. PubMed ID: 19420015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prohibitin and the SWI/SNF ATPase subunit BRG1 are required for effective androgen antagonist-mediated transcriptional repression of androgen receptor-regulated genes.
    Dai Y; Ngo D; Jacob J; Forman LW; Faller DV
    Carcinogenesis; 2008 Sep; 29(9):1725-33. PubMed ID: 18487222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional activity of c-Jun is critical for the suppression of AR function.
    Hsu CC; Hu CD
    Mol Cell Endocrinol; 2013 Jun; 372(1-2):12-22. PubMed ID: 23523566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.